These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31634565)

  • 41. Antimicrobial susceptibility of anaerobic bacteria in Bulgaria.
    Marina M; Ivanova M; Kantardjiev T
    Anaerobe; 2009 Aug; 15(4):127-32. PubMed ID: 19292999
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antimicrobial susceptibilities of clinical isolates of the anaerobic bacteria which can cause aspiration pneumonia.
    Fujita K; Takata I; Sugiyama H; Suematsu H; Yamagishi Y; Mikamo H
    Anaerobe; 2019 Jun; 57():86-89. PubMed ID: 30951830
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro activity of 11 antibiotics against 74 anaerobes isolated from pediatric intra-abdominal infections.
    Goldstein EJ; Citron DM; Vaidya SA; Warren YA; Tyrrell KL; Vreni Merriam C; Fernandez H
    Anaerobe; 2006 Apr; 12(2):63-6. PubMed ID: 16701615
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The sensitivity of anaerobic bacteria to chemotherapeutic agents (Zurich, 1991)].
    Wüst J; Hardegger U
    Schweiz Rundsch Med Prax; 1991 Dec; 80(52):1474-80. PubMed ID: 1815309
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Different breakpoints interpretation yielded distinct resistance rates to moxifloxacin of clinically significant anaerobic bacteria.
    Cobo F; Sadyrbaeva-Dolgova S; Navarro-Marí JM
    Anaerobe; 2021 Dec; 72():102471. PubMed ID: 34715325
    [TBL] [Abstract][Full Text] [Related]  

  • 46. European surveillance study on antimicrobial susceptibility of Gram-positive anaerobic cocci.
    Brazier J; Chmelar D; Dubreuil L; Feierl G; Hedberg M; Kalenic S; Könönen E; Lundgren B; Malamou-Ladas H; Nagy E; Sullivan A; Nord CE;
    Int J Antimicrob Agents; 2008 Apr; 31(4):316-20. PubMed ID: 18180149
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Susceptibility of anaerobic bacteria to antimicrobial agents.
    Collignon PJ; Munro R; Morris G
    Pathology; 1988 Jan; 20(1):48-52. PubMed ID: 3374973
    [TBL] [Abstract][Full Text] [Related]  

  • 48. How to isolate, identify and determine antimicrobial susceptibility of anaerobic bacteria in routine laboratories.
    Nagy E; Boyanova L; Justesen US;
    Clin Microbiol Infect; 2018 Nov; 24(11):1139-1148. PubMed ID: 29458156
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibiotic susceptibility of anaerobic bacteria in Europe.
    Tunér K; Nord CE
    Clin Infect Dis; 1993 Jun; 16 Suppl 4():S387-9. PubMed ID: 8324153
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is there a need for the antibiotic susceptibility testing of anaerobic bacteria?
    Nagy E; Schuetz A
    Anaerobe; 2015 Feb; 31():2-3. PubMed ID: 25464139
    [No Abstract]   [Full Text] [Related]  

  • 51. In vitro susceptibility testing of nonsporing anaerobes to ten antimicrobial agents.
    Rao PS; Shivananda PG
    Indian J Pathol Microbiol; 2000 Apr; 43(2):139-42. PubMed ID: 11217270
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multidrug resistance in anaerobes.
    Boyanova L; Markovska R; Mitov I
    Future Microbiol; 2019 Aug; 14():1055-1064. PubMed ID: 31469008
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recent evolution of antibiotic resistance in the anaerobes as compared to previous decades.
    Boyanova L; Kolarov R; Mitov I
    Anaerobe; 2015 Feb; 31():4-10. PubMed ID: 24875330
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antibiotic susceptibility profiles of oral pathogens.
    Veloo AC; Seme K; Raangs E; Rurenga P; Singadji Z; Wekema-Mulder G; van Winkelhoff AJ
    Int J Antimicrob Agents; 2012 Nov; 40(5):450-4. PubMed ID: 22890195
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antibiotic susceptibility of bacteria associated with endodontic abscesses.
    Baumgartner JC; Xia T
    J Endod; 2003 Jan; 29(1):44-7. PubMed ID: 12540219
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activity of ampicillin/sulbactam, ticarcillin/clavulanate, clarithromycin, and eleven other antimicrobial agents against anaerobic bacteria isolated from infections in children.
    Citron DM; Goldstein EJ; Kenner MA; Burnham LB; Inderlied CB
    Clin Infect Dis; 1995 Jun; 20 Suppl 2():S356-60. PubMed ID: 7548597
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epidemiology and antimicrobial susceptibilities of wound isolates of obligate anaerobes from combat casualties.
    White BK; Mende K; Weintrob AC; Beckius ML; Zera WC; Lu D; Bradley W; Tribble DR; Schnaubelt ER; Murray CK;
    Diagn Microbiol Infect Dis; 2016 Feb; 84(2):144-50. PubMed ID: 26607420
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [First Argentine consensus guidelines for in vitro antimicrobial susceptibility testing of clinically relevant anaerobic bacteria in humans/ Anaerobic Subcommittee of the Asociación Argentina de Microbiología].
    Legaria MC; Bianchini HM; Castello L; Carloni G; Di Martino A; Fernández Canigia L; Litterio M; Rollet R; Rossetti A; Predari SC
    Rev Argent Microbiol; 2011; 43(1):51-66. PubMed ID: 21491069
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Susceptibility of bacterial vaginosis (BV)-associated bacteria to secnidazole compared to metronidazole, tinidazole and clindamycin.
    Petrina MAB; Cosentino LA; Rabe LK; Hillier SL
    Anaerobe; 2017 Oct; 47():115-119. PubMed ID: 28522362
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antimicrobial profiles of periodontal pathogens isolated from periodontitis patients in The Netherlands and Spain.
    van Winkelhoff AJ; Herrera D; Oteo A; Sanz M
    J Clin Periodontol; 2005 Aug; 32(8):893-8. PubMed ID: 15998275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.